CUNISER 500 (25 UI/ml) LYOPHILIZED AND SOLVENT FOR INJECTABLE SOLUTION
CUNISER 500 (25 UI/ml) LYOPHILIZED AND SOLVENT FOR INJECTABLE SOLUTION
Authorised
- Gonadotropin, equine, serum
Product identification
Medicine name:
CUNISER 500IU ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
CUNISER 500 (25 UI/ml) LYOPHILIZED AND SOLVENT FOR INJECTABLE SOLUTION
Active substance:
- Gonadotropin, equine, serum
Target species:
-
Rabbit (female for reproduction)
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Gonadotropin, equine, serum500.00/international unit(s)20.00millilitre(s)
Pharmaceutical form:
-
Powder and solvent for solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Rabbit (female for reproduction)
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Rabbit (female for reproduction)
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG03GA03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- box containing 10 vials of lyophilisate and box containing 10 vials of solvent of 20 ml
- box containing 1 vial of lyophilisate and box containing 1 vial of solvent of 20 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Biogenesis Global S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 19781/21-02-2014/K-0174701
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0124/001
Concerned member states:
-
Greece
-
Portugal
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
